← FDA ENFORCEMENT
D-0018-2025Class II

Fresenius Kabi Compounding, LLC

Recalling firm
Fresenius Kabi Compounding, LLC
Product type
Drug
Status
Terminated
Report date
2024-10-30
Distribution
Product was distributed to 125 direct accounts nationwide.
Firm state
MA
Product quantity
1082 bags
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Risk Management & CAPA
Reason for recall

cGMP violations

Product description

Vancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USP, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-014-58

Code / lot info

Lot # C274-000038004, exp. date 27-Nov-24

Other recalls SPEQ maps to Risk Management & CAPA
2026-07-22Class IAbiomed, Inc.2026-07-22Class IAbiomed, Inc.2026-07-22Class IAbiomed, Inc.2026-07-22Class IAbiomed, Inc.
See all Risk Management & CAPA recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.